Treatment of dystonia in Parkinson's disease.
Tsui
Joseph King Ching
JK
Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, British Columbia, Canada.
D001905:Botulinum Toxins / Q000627:therapeutic use; D015259:Dopamine Agents / Q000627:therapeutic use; D004421:Dystonia / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D005917:Globus Pallidus / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D013238:Stereotaxic Techniques
D015259:Dopamine Agents; D001905:Botulinum Toxins